CHAPTER 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets, 2016
3.2.2. Top winning strategies

3.3. TOP PLAYER POSITIONING, 2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Surge in awareness towards early diagnosis
3.5.1.2. Rise in popularity of POC testing
3.5.1.3. Increase in government expenditure on healthcare

3.5.2. Restraints

3.5.2.1. Limited detection capability and accuracy
3.5.2.2. Regulatory and economic hurdles

3.5.3. Opportunities

3.5.3.1. Increase in adoption of molecular diagnostic testing
3.5.3.2. Untapped markets in the developing economies

CHAPTER 4 PNEUMONIA TESTING MARKET, BY METHOD

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. IMMUNODIAGNOSTICS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. MOLECULAR DIAGNOSTICS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. POINT-OF-CARE (POC) TESTING

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 PNEUMONIA TESTING MARKET, BY TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)

5.2.1. Market size and forecast

5.3. IMMUNOFLUORESCENCE

5.3.1. Market size and forecast

5.4. WESTERN BLOT

5.4.1. Market size and forecast

5.5. POLYMERASE CHAIN REACTION (PCR)

5.5.1. Market size and forecast

5.6. IMMUNOHISTOCHEMISTRY (IHC)

5.6.1. Market size and forecast

5.7. OTHERS

5.7.1. Market size and forecast

CHAPTER 6 PNEUMONIA TESTING MARKET, BY TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. ANALYZERS

6.2.1. Market size and forecast

6.3. CONSUMABLES

6.3.1. Market size and forecast

CHAPTER 7 PNEUMONIA TESTING MARKET, BY END USER

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. HOSPITALS

7.2.1. Market size and forecast

7.3. DIAGNOSTIC CENTERS

7.3.1. Market size and forecast

7.4. HOMECARE

7.4.1. Market size and forecast

7.5. OTHERS

7.5.1. Market size and forecast

CHAPTER 8 PNEUMONIA TESTING MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast, by method
8.2.4. Market size and forecast, by technology
8.2.5. Market size and forecast, by type
8.2.6. Market size and forecast, by end user
8.2.7. Market size and forecast, by country

8.2.7.1. U.S. market size and forecast, by method
8.2.7.2. U.S. market size and forecast, by technology
8.2.7.3. U.S. market size and forecast, by type
8.2.7.4. U.S. market size and forecast, by end user
8.2.7.5. Canada market size and forecast, by method
8.2.7.6. Canada market size and forecast, by technology
8.2.7.7. Canada market size and forecast, by type
8.2.7.8. Canada market size and forecast, by end user
8.2.7.9. Mexico market size and forecast, by method
8.2.7.10. Mexico market size and forecast, by technology
8.2.7.11. Mexico market size and forecast, by type
8.2.7.12. Mexico market size and forecast, by end user

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast, by method
8.3.4. Market size and forecast, by technology
8.3.5. Market size and forecast, by type
8.3.6. Market size and forecast, by end user
8.3.7. Market size and forecast, by country

8.3.7.1. Germany market size and forecast, by method
8.3.7.2. Germany market size and forecast, by technology
8.3.7.3. Germany market size and forecast, by type
8.3.7.4. Germany market size and forecast, by end user
8.3.7.5. France market size and forecast, by method
8.3.7.6. France market size and forecast, by technology
8.3.7.7. France market size and forecast, by type
8.3.7.8. France market size and forecast, by end user
8.3.7.9. UK market size and forecast, by method
8.3.7.10. UK market size and forecast, by technology
8.3.7.11. UK market size and forecast, by type
8.3.7.12. UK market size and forecast, by end user
8.3.7.13. Italy market size and forecast, by method
8.3.7.14. Italy market size and forecast, by technology
8.3.7.15. Italy market size and forecast, by type
8.3.7.16. Italy market size and forecast, by end user
8.3.7.17. Spain market size and forecast, by method
8.3.7.18. Spain market size and forecast, by technology
8.3.7.19. Spain market size and forecast, by type
8.3.7.20. Spain market size and forecast, by end user
8.3.7.21. Rest of Europe market size and forecast, by method
8.3.7.22. Rest of Europe market size and forecast, by technology
8.3.7.23. Rest of Europe market size and forecast, by type
8.3.7.24. Rest of Europe market size and forecast, by end user

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast, by method
8.4.4. Market size and forecast, by technology
8.4.5. Market size and forecast, by type
8.4.6. Market size and forecast, by end user
8.4.7. Market size and forecast, by country

8.4.7.1. Japan market size and forecast, by method
8.4.7.2. Japan market size and forecast, by technology
8.4.7.3. Japan market size and forecast, by type
8.4.7.4. Japan market size and forecast, by end user
8.4.7.5. China market size and forecast, by method
8.4.7.6. China market size and forecast, by technology
8.4.7.7. China market size and forecast, by type
8.4.7.8. China market size and forecast, by end user
8.4.7.9. Australia market size and forecast, by method
8.4.7.10. Australia market size and forecast, by technology
8.4.7.11. Australia market size and forecast, by type
8.4.7.12. Australia market size and forecast, by end user
8.4.7.13. India market size and forecast, by method
8.4.7.14. India market size and forecast, by technology
8.4.7.15. India market size and forecast, by type
8.4.7.16. India market size and forecast, by end user
8.4.7.17. South Korea market size and forecast, by method
8.4.7.18. South Korea market size and forecast, by technology
8.4.7.19. South Korea market size and forecast, by type
8.4.7.20. South Korea market size and forecast, by end user
8.4.7.21. Taiwan market size and forecast, by method
8.4.7.22. Taiwan market size and forecast, by technology
8.4.7.23. Taiwan market size and forecast, by type
8.4.7.24. Taiwan market size and forecast, by end user
8.4.7.25. Rest of Asia-Pacific market size and forecast, by method
8.4.7.26. Rest of Asia-Pacific market size and forecast, by technology
8.4.7.27. Rest of Asia-Pacific market size and forecast, by type
8.4.7.28. Rest of Asia-Pacific market size and forecast, by end user

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast, by method
8.5.4. Market size and forecast, by technology
8.5.5. Market size and forecast, by type
8.5.6. Market size and forecast, by end user
8.5.7. Market size and forecast, by country

8.5.7.1. Brazil market size and forecast, by method
8.5.7.2. Brazil market size and forecast, by technology
8.5.7.3. Brazil market size and forecast, by type
8.5.7.4. Brazil market size and forecast, by end user
8.5.7.5. Saudi Arabia market size and forecast, by method
8.5.7.6. Saudi Arabia market size and forecast, by technology
8.5.7.7. Saudi Arabia market size and forecast, by type
8.5.7.8. Saudi Arabia market size and forecast, by end user
8.5.7.9. South Africa market size and forecast, by method
8.5.7.10. South Africa market size and forecast, by technology
8.5.7.11. South Africa market size and forecast, by type
8.5.7.12. South Africa market size and forecast, by end user
8.5.7.13. Rest of LAMEA market size and forecast, by method
8.5.7.14. Rest of LAMEA market size and forecast, by technology
8.5.7.15. Rest of LAMEA market size and forecast, by type
8.5.7.16. Rest of LAMEA market size and forecast, by end user

CHAPTER 9 COMPANY PROFILES

9.1. ABBOTT LABORATORIES

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. BECTON, DICKINSON AND COMPANY

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segment
9.2.4. Business performance
9.2.5. Key strategic moves and developments

9.3. BIOMERIEUX S.A.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating product solutions
9.3.4. Business performance
9.3.5. Key strategic moves and developments

9.4. BIO-RAD LABORATORIES, INC.

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance

9.5. F. HOFFMANN-LA ROCHE AG

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. HOLOGIC, INC.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments

9.7. MERIDIAN BIOSCIENCE, INC.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments

9.8. QUEST DIAGNOSTICS INCORPORATED

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance

9.9. QUIDEL CORPORATION

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Business performance
9.9.4. Key strategic moves and developments

9.10. THERMO FISHER SCIENTIFIC INC.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance